Live Ready-to-Use Models Now Available – No Wait Times!

GenoBioTX is pleased to announce the availability of ready-to-use knockout (KO), knock-in (KI), and overexpression models for preclinical research. With no wait times, researchers can now accelerate their studies using our live genetically engineered models, ensuring efficiency and reliability in critical research areas.

Advancing Preclinical Research Across Key Areas

Our live models are designed to support a wide range of disease applications, including:

Oncology

  • Knockout and knock-in models for tumor research and targeted therapy development

Neurology

  • Overexpression models for neurodegenerative diseases and CNS disorders

Metabolic & Cardiovascular Research

  • KO/KI models for diabetes, obesity, and atherosclerosis

Autoimmune & Infectious Diseases

  • Genetically modified mice for immune system and pathogen response studies

Immediate Availability for Researchers

By eliminating long lead times, these models allow researchers to rapidly initiate their studies without delays, expediting advancements in drug discovery and therapeutic development.

📄 Explore our full list of available live animal models to find the best fit for your research needs.

📩 Contact us today to discuss your project and secure immediate access to these models.

    News Center

    2024.11.09

    SmocMabTM: Fully Human AntibodyTransgenic Mice Tailored to YourAntigen in 3 Months

    Who We Are GenoBioTX is a well-known contract research organization (CRO) providing genetically engineered animal models, and preclinical drug discovery services to biopharmaceutical companies and life science researchers. Our Services Generate KO HOM mice in just 3 months Provision of at least 3 F0 homozygous mice per project within 3 months Comprehensive and detailed report […]

    2024.11.09

    Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development

    Registration link: https://www.eventbrite.com/e/1021029977147?aff=oddtdtcreator Date: Wednesday, Oct 2nd, 2024; 11:00 am PST, or 2:00 pm EST Webinar Highlights: Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating […]

    Email Back to top